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Identity 
Hugo: S100B 
Other names: NEF; S100; S100Beta 
Location: 21q22.3 
DNA/RNA 
Description 
The gene encompasses 17.3 kb of DNA; 3 exons (the 
first one contains the 5' untranslated region). 
Transcription 
1135 b mRNA; 279 b coding sequence. 
Protein 
Description 
92 amino acids (including initial methionine that is 
generally processed in vivo);  
10.5 kDa monomer (S100B can form homodimers and 
heterodimers with other proteins of the S100 family, 
described for S100A1). 
Expression 
S100B highest levels are found in brain. The protein is 
primarily found in astrocytes. Outside the central 
nervous system it can be found in chondrocytes and 
melanocytes. 
Localisation 
Nuclear and cytoplasmic. It has both intracellular and 
extracellular roles. 
Function 
The exact function of S100B is not fully understood. It 
inhibits microtubule assembly, has been involved in the 
regulation of cell cycle progression and differentiation 
and is able to induce neurite extension. This latest 
effect seems to be dependent on the concentration of 
S100B and occurs at nanomolar concentrations. 
But micromolar levels of extracellular S100B stimulate 
apoptosis in vitro. Calcium binding induces a 
conformational change in S100B that allows the 
interaction with a variety of target proteins. These 
include p53 tumour suppressor, the microtubule-
associated protein tau, the cytoskeletal protein tubulin 
(and its prokaryotic ancestor FtsZ), the scaffold protein 
IQGAP1, the intermediate filament protein glial 
fibrillary acidic protein (GFAP), the actin capping 
protein CapZ and the giant phosphoprotein AHNAK. 
Over-expression of S100B has been proposed to play a 
role in different neuro-pathologies. 
Homology 
S100B belongs to the S100 family of calcium binding 
proteins, a highly homologous family. These proteins 
contain two EF-hand calcium binding domains. The 
S100 genes are present exclusively in vertebrates. 
Mutations 
Note: Have not been reported. 
Implicated in 
Disease 
Overexpression of S100B has been generally linked to 
neurodegeneration. It is over-expressed in the brain of 
patients suffering from Alzheimer's disease, epilepsy or 
amyotrophic lateral sclerosis. The gene coding for 
S100B maps in the Down's syndrome region of 
chromosome 21, and its over-expression, due to the 
trisomic state, may be responsible for the neurological 
disturbances in Down's syndrome. 
Oncogenesis 
S100B may be involved in the proliferation of 
melanoma cells. It has been shown to be elevated in  
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primary malignant melanomas. However, S100B is 
used as a predictor of survival prognosis as elevated 
levels of S100B in serum are associated with the 
survival rate. 
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